The non-invasive EMG wristband technology he developed now powers Meta's new Neural Band product. At Waypoint, Patrick will accelerate Al-powered drug discovery efforts to develop more effective programmable therapies for patients, faster.
We are excited to announce Patrick Kaifosh as Waypoint's Chief Technology Officer! A pioneer at the intersection of Al and neurotechnology, he previously co-founded CTRL-Labs (acq. Meta 2019) where he served as CSO, before leading research as Director of Research Science at Meta.